STOCK TITAN

[SCHEDULE 13G] WORK Medical Technology Group LTD SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

WORK Medical Technology Group LTD (WOK) Schedule 13G discloses that Bigger Capital Fund, LP and related reporting persons beneficially owned 7,897,548 Class A Ordinary Shares as of September 25, 2025, representing approximately 9.99% of the Class A shares outstanding immediately after the offering (79,054,538 shares basis). The filing states the holdings exclude 5,102,230 Class A Ordinary Shares issuable upon exercise of pre-funded warrants subject to a 9.99% ownership limitation. Reporting persons disclaim sole ownership and state the stake is not held to influence control.

WORK Medical Technology Group LTD (WOK) Schedule 13G rivela che Bigger Capital Fund, LP e le persone di segnalazione correlate detengono beneficiariamente 7.897.548 azioni ordinarie di Classe A al 25 settembre 2025, pari a circa 9,99% delle azioni di Classe A in circolazione subito dopo l'offerta (base di 79.054.538 azioni). La nota di deposito indica che le partecipazioni escludono 5.102.230 azioni ordinarie di Classe A che sarebbero emesse all'esercizio di warrant prefinanziati soggetti a una limitazione di proprietà del 9,99%. Le persone che riportano la posse non dichiarano appartenenza esclusiva e affermano che la quota non è detenuta per influenzare il controllo.

WORK Medical Technology Group LTD (WOK) Schedule 13G indica que Bigger Capital Fund, LP y las personas reportantes relacionadas poseen beneficiosamente 7,897,548 Acciones Ordinarias Clase A al 25 de septiembre de 2025, aproximadamente el 9,99% de las acciones de Clase A en circulación inmediatamente después de la oferta (base de 79,054,538 acciones). El expediente señala que las participaciones excluyen 5,102,230 acciones ordinarias de Clase A que podrían emitirse mediante la exerci­ción de warrants prefinanciados sujetos a una limitación de propiedad del 9,99%. Las personas reportantes declaran no poseer la titularidad exclusiva y señalan que la participación no se mantiene para influir en el control.

WORK Medical Technology Group LTD (WOK) Schedule 13G은 Bigger Capital Fund, LP 및 관련 보고 대상자가 2025년 9월 25일 기준으로 7,897,548주 Class A 보통주를 보유하고 있으며, 이는 발행 직후 Class A 주식의 약 9.99%에 해당합니다(주식 수 79,054,538주를 기준으로). 신고서는 피합병 전매권(pre-funded warrants) 행사에 의해 9.99%의 소유 제한에 따라 주어질 수 있는 5,102,230주를 제외하고 있다고 명시합니다. 보고 대상자는 단독 소유를 부인하며 이 지분은 통제에 영향을 주기 위한 것이 아니라고 밝힙니다.

WORK Medical Technology Group LTD (WOK) Schedule 13G révèle que Bigger Capital Fund, LP et les personnes déclarantes associées détiennent des actions ordinaires de Classe A en bénéficiaire net au 25 septembre 2025, soit environ 9,99% des actions de Classe A en circulation immédiatement après l'offre (base de 79 054 538 actions). Le dossier indique que les participations excluent 5 102 230 actions ordinaires de Classe A susceptibles d'être émises lors de l'exercice de warrants préfinancés soumis à une restriction de propriété de 9,99%. Les personnes déclarantes démentent une propriété exclusive et indiquent que la participation n'est pas détenue dans le but d'influencer le contrôle.

WORK Medical Technology Group LTD (WOK) Schedule 13G offenbart, dass Bigger Capital Fund, LP und verwandte meldende Personen am 25. September 2025 insgesamt 7.897.548 Class A Stammaktien besitzen, was ca. 9,99% der ausstehenden Class A Aktien unmittelbar nach der Emission entspricht (Basis 79.054.538 Aktien). Die Einreichung erklärt, dass die Bestände 5.102.230 Class A Stammaktien ausschließen, die durch Ausübung von vorfinanzierten Warrants entstehen könnten und einer Eigentumsobergrenze von 9,99% unterliegen. Meldepflichtige Personen bestreiten das alleinige Eigentum und geben an, dass die Beteiligung nicht dazu dient, die Kontrolle zu beeinflussen.

WORK Medical Technology Group LTD (WOK) Schedule 13G يكشف أن Bigger Capital Fund, LP والأشخاص المبلّغون ذوو الصلة امتلكوا فعلياً 7,897,548 سهماً عادياً من الفئة A حتى 25 سبتمبر 2025، وهو ما يمثل حوالي 9.99% من أسهم الفئة A القائمة بعد العرض (قاعدة 79,054,538 سهماً). يذكر الملف أن الحيازة تستبعد 5,102,230 سهماً من الفئة A قابلة للإصدار بموجب ممارسة سندات مضمونة مُسبقاً تضمّ 9.99% كحد أعلى للملكية. ينفي الأشخاص المبلّغون امتلاكاً وحيداً ويؤكدون أن الحصة ليست مملوكة للتأثير في السيطرة.

WORK Medical Technology Group LTD (WOK) Schedule 13G 披露, Bigger Capital Fund, LP及相关报告人截至2025年9月25日实际拥有7,897,548股A类普通股,约为<9.99%

Positive
  • Disclosed a material minority stake: 7,897,548 Class A Ordinary Shares (~9.99%)
  • Filed under Schedule 13G: Indicates the position is presented as passive and not intended to influence control
  • Provides clear identification: Names, addresses, and relationships of Bigger Capital, Bigger GP, and Michael Bigger are listed
Negative
  • None.

Insights

TL;DR Bigger Capital and affiliates disclosed a near-10% passive stake in WOK, material for ownership tables but reported as non-control.

The filing shows a significant minority position of 7,897,548 Class A Ordinary Shares, equal to approximately 9.99% of outstanding Class A shares immediately post-offering. This is material to cap table and investor disclosure because it approaches the 10% threshold that triggers further reporting and potential limitations tied to pre-funded warrants. The filing clarifies voting and dispositive power is shared through the fund structure and includes standard disclaimers about beneficial ownership attribution among the fund, GP and managing member.

TL;DR The Schedule 13G indicates a passive stake; reporting persons certify holdings are not intended to influence control.

The statement is filed under Schedule 13G reflecting a passive investment profile rather than an active solicitation of control. It identifies the relationships among Bigger Capital Fund, Bigger Capital Fund GP, LLC and Michael Bigger and discloses shared voting and dispositive power. The certification in Item 10 asserts the securities were not acquired to change or influence issuer control, consistent with 13G filing practice. A joint filing agreement is referenced as Exhibit 99.1.

WORK Medical Technology Group LTD (WOK) Schedule 13G rivela che Bigger Capital Fund, LP e le persone di segnalazione correlate detengono beneficiariamente 7.897.548 azioni ordinarie di Classe A al 25 settembre 2025, pari a circa 9,99% delle azioni di Classe A in circolazione subito dopo l'offerta (base di 79.054.538 azioni). La nota di deposito indica che le partecipazioni escludono 5.102.230 azioni ordinarie di Classe A che sarebbero emesse all'esercizio di warrant prefinanziati soggetti a una limitazione di proprietà del 9,99%. Le persone che riportano la posse non dichiarano appartenenza esclusiva e affermano che la quota non è detenuta per influenzare il controllo.

WORK Medical Technology Group LTD (WOK) Schedule 13G indica que Bigger Capital Fund, LP y las personas reportantes relacionadas poseen beneficiosamente 7,897,548 Acciones Ordinarias Clase A al 25 de septiembre de 2025, aproximadamente el 9,99% de las acciones de Clase A en circulación inmediatamente después de la oferta (base de 79,054,538 acciones). El expediente señala que las participaciones excluyen 5,102,230 acciones ordinarias de Clase A que podrían emitirse mediante la exerci­ción de warrants prefinanciados sujetos a una limitación de propiedad del 9,99%. Las personas reportantes declaran no poseer la titularidad exclusiva y señalan que la participación no se mantiene para influir en el control.

WORK Medical Technology Group LTD (WOK) Schedule 13G은 Bigger Capital Fund, LP 및 관련 보고 대상자가 2025년 9월 25일 기준으로 7,897,548주 Class A 보통주를 보유하고 있으며, 이는 발행 직후 Class A 주식의 약 9.99%에 해당합니다(주식 수 79,054,538주를 기준으로). 신고서는 피합병 전매권(pre-funded warrants) 행사에 의해 9.99%의 소유 제한에 따라 주어질 수 있는 5,102,230주를 제외하고 있다고 명시합니다. 보고 대상자는 단독 소유를 부인하며 이 지분은 통제에 영향을 주기 위한 것이 아니라고 밝힙니다.

WORK Medical Technology Group LTD (WOK) Schedule 13G révèle que Bigger Capital Fund, LP et les personnes déclarantes associées détiennent des actions ordinaires de Classe A en bénéficiaire net au 25 septembre 2025, soit environ 9,99% des actions de Classe A en circulation immédiatement après l'offre (base de 79 054 538 actions). Le dossier indique que les participations excluent 5 102 230 actions ordinaires de Classe A susceptibles d'être émises lors de l'exercice de warrants préfinancés soumis à une restriction de propriété de 9,99%. Les personnes déclarantes démentent une propriété exclusive et indiquent que la participation n'est pas détenue dans le but d'influencer le contrôle.

WORK Medical Technology Group LTD (WOK) Schedule 13G offenbart, dass Bigger Capital Fund, LP und verwandte meldende Personen am 25. September 2025 insgesamt 7.897.548 Class A Stammaktien besitzen, was ca. 9,99% der ausstehenden Class A Aktien unmittelbar nach der Emission entspricht (Basis 79.054.538 Aktien). Die Einreichung erklärt, dass die Bestände 5.102.230 Class A Stammaktien ausschließen, die durch Ausübung von vorfinanzierten Warrants entstehen könnten und einer Eigentumsobergrenze von 9,99% unterliegen. Meldepflichtige Personen bestreiten das alleinige Eigentum und geben an, dass die Beteiligung nicht dazu dient, die Kontrolle zu beeinflussen.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BIGGER CAPITAL FUND L P
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member of Bigger Capital Fund GP, LLC, its general partner
Date:09/29/2025
Bigger Capital Fund GP, LLC
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:09/29/2025
Bigger Michael
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger
Date:09/29/2025
Exhibit Information

99.1 - Joint Filing Agreement

FAQ

How many Class A Ordinary Shares of WOK does Bigger Capital own?

As of September 25, 2025, Bigger Capital beneficially owned 7,897,548 Class A Ordinary Shares.

What percentage of WOK does the reported stake represent?

The reported amount represented approximately 9.99% of Class A Ordinary Shares outstanding immediately after the offering (79,054,538 share basis).

Are pre-funded warrants included in the beneficial ownership count?

No. The filing states 5,102,230 Class A Ordinary Shares issuable upon exercise of pre-funded warrants are not included and are subject to a 9.99% beneficial ownership limitation.

Did the reporting persons claim control of WOK?

No. The filing is made on Schedule 13G and includes an Item 10 certification stating the securities were not acquired to change or influence control.

Who are the reporting persons behind the filing?

The reporting persons are Bigger Capital Fund, LP, Bigger Capital Fund GP, LLC, and Michael Bigger, all with the listed Las Vegas address.
WORK Medical Technology Group LTD

NASDAQ:WOK

WOK Rankings

WOK Latest News

WOK Latest SEC Filings

WOK Stock Data

5.39M
47.45M
13.56%
0.2%
1.12%
Medical Devices
Healthcare
Link
China
Hangzhou